A detailed history of Peterson Wealth Services transactions in Novo Nordisk A S stock. As of the latest transaction made, Peterson Wealth Services holds 39,946 shares of NVO stock, worth $4.47 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
39,946
Previous 39,632 0.79%
Holding current value
$4.47 Million
Previous $5.09 Million 12.05%
% of portfolio
1.99%
Previous 1.85%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $38,530 - $46,129
314 Added 0.79%
39,946 $5.7 Million
Q1 2024

May 01, 2024

SELL
$102.11 - $135.92 $99,250 - $132,114
-972 Reduced 2.39%
39,632 $5.09 Million
Q4 2023

Jan 31, 2024

BUY
$87.78 - $105.45 $38,184 - $45,870
435 Added 1.08%
40,604 $4.2 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $1.9 Million - $4.17 Million
20,887 Added 108.32%
40,169 $3.65 Million
Q2 2023

Jul 13, 2023

BUY
$155.98 - $172.65 $3.01 Million - $3.33 Million
19,282 New
19,282 $3.12 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $253B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Peterson Wealth Services Portfolio

Follow Peterson Wealth Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peterson Wealth Services, based on Form 13F filings with the SEC.

News

Stay updated on Peterson Wealth Services with notifications on news.